Intercept Pharmaceuticals Inc Propriété du management
Quel est le Propriété du management de Intercept Pharmaceuticals Inc?
Le Propriété du management de Intercept Pharmaceuticals Inc est 4.50%
Quelle est la définition de Propriété du management?
La propriété d'un initié est calculée en divisant le nombre total d'actions possédées par des initiés (actionnaires détenant plus de 5% de la société ou un dirigeant ou un administrateur de la société) par le nombre total d'actions en circulation.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Propriété du management des entreprises dans Health Care secteur sur NASDAQ par rapport à Intercept Pharmaceuticals Inc
Que fait Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Entreprises avec propriété du management similaire à Intercept Pharmaceuticals Inc
- ATTRAQT plc a Propriété du management de 4.50%
- Colony Capital a Propriété du management de 4.50%
- Deutsche Pfandbriefbank AG a Propriété du management de 4.50%
- BGSF Inc a Propriété du management de 4.50%
- Macquarie a Propriété du management de 4.50%
- Stepan Co a Propriété du management de 4.50%
- Intercept Pharmaceuticals Inc a Propriété du management de 4.50%
- Stoneridge a Propriété du management de 4.51%
- RigNet Inc a Propriété du management de 4.51%
- Marin Software Inc a Propriété du management de 4.51%
- Plus500 a Propriété du management de 4.51%
- Detection Technology Oyj a Propriété du management de 4.51%
- Banimmo SA a Propriété du management de 4.51%